Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Parkinson's disease Treatmentmarket was valued at USD 3.94billion in 2016 and is projected to reach USD 6.65billionby 2025, growing at a CAGR of 5.99% from 2017 to 2025.
The disorder has currently ongoing research for finding a reliable treatment method and is the topic of interest for major players in the healthcare and medical sector. The market is thus expected to grow at a high CAGR during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Geriatric Population
1.2 Growing number of cases of Parkinson's disorder
1.3 Availability of fund
2. Market Restraints
2.1 Presence of Alternatives
Market Segmentation:
1. By Patient Care Setting:
1.1 Clinics
1.2 Hospitals
2. By Distribution Channel:
2.1 Hospital Pharmacies
2.2 Retailer Pharmacies
2.3 Online Pharmacies
3. By Drug Class:
3.1 Carbidopa/Levodopa
3.2 Dopamine Receptor Agonists
3.3 Mao Inhibitors
3.4 Comt Inhibitors
3.5 Anticholinergics
3.6 Other Drugs
4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. GSK
2. Merck
3. Novartis
4. Teva
5. BoehringerIngelheim
6. Impax
7. Abbvie
8. Valeant Pharmaceuticals
9. Lundbeck
10. Sun Pharma
11. Wockhardt
12. Acadia
13. UCB
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Parkinson's disease Treatmentmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Request Sample 
Request Discount 
Inquire Before Buy
